SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YellowLegalPad
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy7/18/2007 7:40:45 PM
   of 1182
 
Ignore

=================================

CancerCat:Brain
DrugName:Autologous Tumor Lysate-Pulsed Dendritic Cell
VacTypeDesc:Dendritic Cell

CompanyName:
Hosp - Jonsson Comprehensive Cancer Center

TrialName:
Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery
for Malignant Glioma

Trial Number:NCT00107185
Phase:1
Enroll:18
StartDate:04/05/2005
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107185?order=1
AboutTheDrug:

VacTrialID:3
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:Autologous Tumor Lysate-Pulsed Dendritic Cell
VacTypeDesc:Dendritic Cell

CompanyName:
Hosp - Jonsson Comprehensive Cancer Center

TrialName:
Vaccine Therapy in Treating Patients With Malignant Glioma

Trial Number:NCT00068510
Phase:1
Enroll:18
StartDate:06/01/2003
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00068510?order=2
AboutTheDrug:

VacTrialID:2
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:DCVAX-Brian
VacTypeDesc:Dendritic Cell

CompanyName:
Northwest Biotherapeutics Inc

TrialName:
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Canc
cer

Trial Number:NCT00045968
Phase:2
Enroll:141
StartDate:12/01/2006
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00045968?order=1
AboutTheDrug:http://www.nwbio.com/dcvax_brain.php

VacTrialID:1
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:Oncophage
VacTypeDesc:Heat Shock Protein

CompanyName:
Antigenics

TrialName:
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients W
With Recurrent or Progressive Glioma

Trial Number:NCT00293423
Phase:1
Enroll:50
StartDate:11/21/2005
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00293423?order=1
AboutTheDrug:http://www.antigenics.com/products/cancer/oncophage/

VacTrialID:21
DrugPatentLink:
PriorTrialLink:http://pub.ucsf.edu/newsservices/releases/200704171/
PriorTrialLink1:http://www.caring4cancer.com/go/kidney/news?NewsItemId=20070416elin011.xml
PartnerID:
PartnerLink:
Commentary:http://www.abc.net.au/rn/healthreport/stories/2007/1867372.htm

=================================
CancerCat:Brain
DrugName:Cotara
VacTypeDesc:Non-Vaccine - Cotara - TNT (tumor necrosis therpy)

CompanyName:
Peregrine Pharmaceuticals

TrialName:
Brain Cancer - Glioblastoma

Trial Number:Cotara - India
Phase:2
Enroll:40
StartDate:
EndDate:
TrialLink:http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-25-2007/0004614602&EDATE=
AboutTheDrug:

VacTrialID:10
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:CDX-110
VacTypeDesc:Peptide

CompanyName:
Celldex Therapeutics

TrialName:
Phase II/III Study of CDX-110 in Patients With GBM (ACT III)

Trial Number:NCT00458601
Phase:3
Enroll:375
StartDate:04/01/2007
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00458601?order=1
AboutTheDrug:http://www.celldextherapeutics.com/wt/page/cdx_110

VacTrialID:22
DrugPatentLink:http://www.freshpatents.com/Egfrviii-specific-monoclonal-antibody-and-egfrviii-ribozymes-and-use-to-detect-treat-or-prevent-egfrviii-associated-cancer-dt20051006ptan20050222059.php
PriorTrialLink:http://www.biospace.com/news_story.aspx?NewsEntityId=58603
PriorTrialLink1:http://www.genengnews.com/news/bnitem.aspx?name=18403748&taxid=29
PartnerID:
PartnerLink:
Commentary:http://sanjose.bizjournals.com/sanjose/stories/2007/04/09/story4.html

=================================
CancerCat:Brain
DrugName:HER-2/Neu Pulsed DC1 Vaccine
VacTypeDesc:Peptide

CompanyName:
Hosp - University of Pennsylvania - Dr. Czerniecki

TrialName:
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Du
uctal Carcinoma In Situ of the Breast

Trial Number:NCT00107211
Phase:1
Enroll:30
StartDate:04/05/2005
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107211?order=3
AboutTheDrug:

VacTrialID:4
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Brain
DrugName:NV1020 - Oncolytic Virus
VacTypeDesc:Virus

CompanyName:
MediGene AG

TrialName:
Brain Cancer - Glioblastoma

Trial Number:NV1020-Glioblastoma - Not Started
Phase:0
Enroll:0
StartDate:
EndDate:
TrialLink:http://www.labtechnologist.com/news/ng.asp?n=78088-medigene-herpes-cancer-virus-tumours
AboutTheDrug:http://www.medigene.de/englisch/ProjektHSV.php

VacTrialID:8
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Breast Cancer
DrugName:TroVax
VacTypeDesc:Antigen

CompanyName:
Oxford BioMedica

TrialName:
Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breas
st Cancer in Remission

Trial Number:NCT00227474
Phase:2
Enroll:120
StartDate:09/26/2005
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00227474?order=3
AboutTheDrug:http://www.oxfordbiomedica.co.uk/trovax.htm

VacTrialID:18
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:
Commentary:

=================================
CancerCat:Colorectal Cancer
DrugName:NV1020 - Oncolytic Virus
VacTypeDesc:Virus

CompanyName:
MediGene AG

TrialName:
Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus N
NV1020 to Treat Colorectal Cancer Metastatic to Liver

Trial Number:NCT00149396
NCT00149396
Phase:2
Enroll:27
StartDate:07/01/2004
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00149396?order=1
AboutTheDrug:

VacTrialID:7
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Head and Neck
DrugName:MAGE-A3
VacTypeDesc:Antigen

CompanyName:
GlaxoSmithKline

TrialName:
MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Nec
ck

Trial Number:NCT00257738
Phase:1
Enroll:90
StartDate:11/01/2005
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00257738?order=1
AboutTheDrug:http://www.gsk-us.com/ControllerServlet?appId=4&pageId=402&newsid=910

VacTrialID:19
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Lung Cancer
DrugName:MAGE-A3
VacTypeDesc:Antigen

CompanyName:
GlaxoSmithKline

TrialName:
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Ther
rapy in Patients With Non-Small Cell Lung Cancer

Trial Number:NCT00480025
Phase:3
Enroll:2270
StartDate:06/01/2007
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00480025?order=3
AboutTheDrug:http://www.medicalnewstoday.com/articles/73327.php

VacTrialID:15
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Lung Cancer
DrugName:Stimuvax
VacTypeDesc:Tumor Cell - Autologous

CompanyName:
Merck KGaA

TrialName:
Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Ca
ancer

Trial Number:NCT00409188
Phase:3
Enroll:1322
StartDate:12/01/2006
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00409188?order=1
AboutTheDrug:http://www.biomira.com/professionals/biomiraVaccines/BLP25/

VacTrialID:14
DrugPatentLink:
PriorTrialLink:http://www.biomira.com/pipeline/stimuvax/
PriorTrialLink1:http://www.psa-rising.com/wiredbird/biomira_stimuvax06.html
PartnerID:BIOM
PartnerLink:http://www.healthcare-digital.co.uk/Biomira-announces-new-COO_1116.aspx
Commentary:http://www.biomira.com/pipeline/stimuvax/

=================================
CancerCat:Lung Cancer
DrugName:VaxImmune
VacTypeDesc:Vaccine Adjuvant - VaxImmune

CompanyName:
Coley Pharmaceutical

TrialName:
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Ther
rapy in Patients With Non-Small Cell Lung Cancer

Trial Number:NCT00480025
Phase:3
Enroll:2270
StartDate:06/01/2007
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00480025?order=3
AboutTheDrug:http://money.aol.com/news/articles/_a/coley-pharmaceutical-groups-vaccine/n20070605095209990013

VacTrialID:20
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Melanoma
DrugName:UVIDEM (IDD-3)
VacTypeDesc:Dendritic Cell

CompanyName:
IDM Pharma, Inc.

TrialName:
Vaccine Therapy in Treating Patients With Unresected Stage III or Stag
ge IV Melanoma

Trial Number:NCT00107159
Phase:2
Enroll:30
StartDate:01/01/2005
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107159?order=1
AboutTheDrug:

VacTrialID:5
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:
Commentary:

=================================
CancerCat:Ovarian Cancer
DrugName:Abagovomab
VacTypeDesc:Anti-Idiotype

CompanyName:
Menarini Group

TrialName:
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovoma
ab to Treat Ovarian Cancer Patients (MIMOSA)

Trial Number:NCT00418574
Phase:3
Enroll:870
StartDate:12/01/2006
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00418574?order=1
AboutTheDrug:

VacTrialID:13
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Pancreatic
DrugName:GV1001
VacTypeDesc:Peptide

CompanyName:
Pharmexa A/S

TrialName:
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treati
ing Patients With Locally Advanced or Metastatic Pancreatic Cancer

Trial Number:NCT00425360
Phase:3
Enroll:1110
StartDate:09/01/2006
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00425360?order=3
AboutTheDrug:http://www.pharmexa.com/site.asp?p=506

VacTrialID:12
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Pancreatic
DrugName:GV1001
VacTypeDesc:Peptide

CompanyName:
Pharmexa A/S

TrialName:
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monoth
herapy in Pancreatic Cancer.
`

Trial Number:NCT00358566
Phase:3
Enroll:520
StartDate:06/01/2006
EndDate:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00358566?order=1
AboutTheDrug:http://www.pharmexa.com/site.asp?p=506

VacTrialID:6
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Prostate
DrugName:VPM4001
VacTypeDesc:Tumor Cell - Allogeneic

CompanyName:
Vakzine Projekt Management

TrialName:
Phase I/II Prostate Cancer

Trial Number:Unknown
Phase:2
Enroll:30
StartDate:
EndDate:
TrialLink:http://www.psa-rising.com/wiredbird/vakzinepm0607.html
AboutTheDrug:http://www.vakzine-manager.de/Allogeneic_Cancer_Va.167.0.html?&L=1#553

VacTrialID:23
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:
PartnerLink:
Commentary:

=================================
CancerCat:Renal Cell Carcinoma
DrugName:TroVax
VacTypeDesc:Antigen

CompanyName:
Oxford BioMedica

TrialName:
TroVax Renal Immunotherapy Survival Trial

Trial Number:NCT00397345
Phase:3
Enroll:700
StartDate:09/01/2006
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00397345?order=1
AboutTheDrug:http://www.oxfordbiomedica.co.uk/trovax.htm

VacTrialID:16
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:http://www.drugresearcher.com/news/ng.asp?n=75395-sanofi-aventis-oxford-biomedica-trovax-cancer-vaccine-glaxosmithkline
Commentary:

=================================
CancerCat:Renal Cell Carcinoma
DrugName:TroVax
VacTypeDesc:Antigen

CompanyName:
Oxford BioMedica

TrialName:
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment
t of Stage IV Renal Cell Cancer

Trial Number:NCT00083941
Phase:2
Enroll:25
StartDate:08/01/2004
EndDate:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00083941?order=2
AboutTheDrug:http://www.oxfordbiomedica.co.uk/trovax.htm

VacTrialID:17
DrugPatentLink:
PriorTrialLink:
PriorTrialLink1:
PartnerID:SNY
PartnerLink:
Commentary:

=================================
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News